# CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
> **ANDA202894** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2015-10-30
## Drug
- **FDA Application Number:** ANDA202894
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
- **Generic name:** CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** GLENMARK SPECLT
- **Manufacturer:** Glenmark Pharmaceuticals Inc. USA
- **First approval:** 2015-10-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202894)
---
*AI Analytics · CC0 1.0*